Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2025-12-25 @ 12:40 AM
NCT ID:
NCT05818267
Eligibility Criteria:
Inclusion Criteria:
* Patients with histologically or cytologically confirmed metastatic colorectal cancer who have measurable metastatic disease according to the Resolute Efficacy Criteria for Solid Tumors (RECIST) version 1.1.
* Received standard second-line therapy, achieved stable disease(SD) and above by recist1.1 tumor assessment and maintained for 3 months.
* Eastern Oncology Collaborative Group(ECOG) physical status of 0 or 1 at trial entry and life expectancy ≥ 3 months.
* No bone marrow suppression and normal heart, lung, liver and kidney function.
* Voluntary participation in research.
Exclusion Criteria:
* Concurrent primary tumors of other types.
* MSI-H/dMMR type mCRC patients.
* Heart, liver, kidney, bone marrow insufficiency or mental abnormalities.
* Intolerant to treatment methods
* Concurrent participants in other clinical trials.
* Pregnant or lactating women.
* Patients deemed unsuitable for study participation by the remaining investigators.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT05818267
Study Brief:
Protocol Section:
NCT05818267